Nexxen holder files to sell 28,270 shares

Nexxen International Ltd. has a security holder filing to sell ordinary shares under a Form 144 notice.

Rhea-AI Filing Summary

Nexxen International Ltd. has a security holder filing to sell ordinary shares under a Form 144 notice. The filing covers 28,270 ordinary shares to be sold through Oppenheimer & Co. Inc., with an aggregate market value of $272,946.85, and references trading on Nasdaq with an anticipated sale date of July 13, 2026. The shares relate to restricted stock units (RSUs) that vested on March 31, 2026, when 56,540 shares were issued to the holder for no cash consideration.

Filing Explained

The filing records a proposed disposition of 28,270 shares, while the disclosed 56,540-share RSU-vesting issuance is already recorded and not a completed sale.

The July 13 Form 144 identifies 28,270 Nexxen International Ltd. ordinary shares to be sold through Oppenheimer & Co.

The filing records the transaction as a proposed sale, not as a completed sale.

In its securities-acquisition section, the filing reports 56,540 ordinary shares acquired on 2026-03-31 as shares issued upon vesting of RSUs, with no consideration.

That entry describes an earlier share issuance, while the 28,270-share entry describes securities to be sold; the filing does not state that the proposed sale was executed.

Key Figures

Shares to be sold: 28,270 ordinary shares Aggregate market value: $272,946.85 Proposed sale date: 07/13/2026 +2 more

5 metrics

Shares to be sold 28,270 ordinary shares Ordinary shares covered by the Form 144 notice for proposed sale

Aggregate market value $272,946.85 Market value associated with the 28,270 ordinary shares to be sold

Proposed sale date 07/13/2026 Anticipated date for sale of the Form 144 shares

Shares issued from RSU vesting 56,540 shares Ordinary shares issued upon vesting of RSUs on March 31, 2026

RSU vesting date 03/31/2026 Date on which RSUs vested and shares were issued with no consideration

Key Terms

RSUs, No consideration, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is disclosed for NEXN in this Form 144 filing?

The notice covers a planned sale of 28,270 ordinary shares of Nexxen International Ltd. The shares are to be sold through Oppenheimer & Co. Inc. and are listed for trading on Nasdaq.

What is the aggregate market value of the Nexxen (NEXN) shares in the Form 144?

The filing lists an aggregate market value of $272,946.85 for the 28,270 ordinary shares covered. This value reflects the market calculation reported in the Form 144 notice for the planned sale.

When are the Nexxen (NEXN) shares expected to be sold under this Form 144?

The Form 144 indicates an anticipated sale date of July 13, 2026 for the 28,270 ordinary shares. This date marks when the holder expects to begin selling the securities through the designated broker.

How were the Nexxen (NEXN) shares obtained that are listed in the Form 144?

The shares stem from restricted stock units (RSUs) that vested on March 31, 2026. On that vesting date, 56,540 ordinary shares of Nexxen International Ltd. were issued to the holder as equity compensation.

Did the holder pay cash consideration for the Nexxen (NEXN) shares from RSU vesting?

No, the Form 144 states there was “No consideration, shares issued upon vesting of RSUs.” The 56,540 shares were granted as part of an equity compensation program without a cash purchase price.

Which broker is handling the proposed Nexxen (NEXN) share sale in the Form 144?

The proposed sale of 28,270 ordinary shares is listed with Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, as the broker handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:07 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001980184
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nexxen International Ltd.
SEC File Number	001-40504
Address of Issuer	82 YIGAL ALON STREET 13TH FLOOR TEL AVIV ISRAEL 6789124
Phone	972-3-545-3900
Name of Person for Whose Account the Securities are To Be Sold	Carmi Yaniv
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	28270	272946.85	56284083	07/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	03/31/2026	Shares issued upon vesting of RSUs	Nexxen International Ltd.			56540	03/31/2026	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	10b5-1 remark: The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 05-16-2025.
Date of Notice	07/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Yaniv Carmi By: /s/ Liron Avigdor Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)